Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Nuvectis Pharma Stock Surges 97% While Insider Buyers See 344% Gains
Nuvectis Pharma insiders reap massive rewards as stock jumps 97%. Learn what recent insider transactions suggest about the company's long-term outlook.
FDA Approves BESREMi Pen for Polycythemia Vera Self-Administration
The FDA has approved PharmaEssentia’s BESREMi Pen for adult polycythemia vera patients, offering a convenient self-administration treatment option.
FDA Issues CRL for Sobi's NASP Gout Treatment Over Manufacturing Data
Sobi receives an FDA Complete Response Letter for its NASP biologics license application for uncontrolled gout, citing manufacturing control deficiencies.
HHS & FDA Move to Fast-Track Early Drug Research and US Clinical Trials
HHS unveils a new blueprint to fast-track early drug research and streamline FDA IND applications, aiming to keep clinical trials and biotech in the US.
PRF-110 Preclinical Results Match Zynrelef for Post-Operative Pain Relief
PRF Technologies reports expanded preclinical results for PRF-110, showing comparable analgesic efficacy to Zynrelef for post-operative pain management.
MIRA Pharmaceuticals Unveils Mira-55 Preclinical Data for Chronic Pain
MIRA Pharmaceuticals reports positive preclinical data for Mira-55, a novel cannabinoid analog for chronic inflammatory pain and anxiety without THC effects.
FDA Rejects Cytisinicline NDA Due to Manufacturing Issues, Not Safety
Achieve Life Sciences faces an FDA NDA rejection for cytisinicline over third-party manufacturing issues, but clinical safety and efficacy remain uncompromised.
Preclinical Oncology Models Improve Drug Toxicity Prediction in Trials
Emerging human-based preclinical models improve drug toxicity prediction in oncology, offering complementary tools to traditional animal testing in trials.
Epidermolysis Bullosa Treatment: FDA Grants Fast Track to TolaSure Gel
BioMendics announces that the US FDA has granted Fast Track Designation to BM-3103 (TolaSure Gel) for treating epidermolysis bullosa simplex.
US Biotech Job Market Gains: Pharma Collaborates on Onshoring Talent
At BIO 2026, leading US biopharma manufacturers establish regional training networks to manage rising onshoring talent and employment demands.
Skin Cancer Prevention and Treatment: bioAffinity Reveals siRNA Data
BioAffinity Technologies announces successful preclinical in vitro results using targeted siRNA platforms to eliminate common skin cancer cells.
Proteina Signs Parkinson's Disease Biomarkers Deal With Top US Pharma
Proteina finalizes a strategic analytics service contract with a US pharma company to track protein complexes in preclinical neurodegeneration studies.
1
2
3
4
5
6
